Searched for
BIOCON BIOPHARMACEUTICALS
“Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommendedBiocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges im...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
- Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Biocon appoints Peter Bains as Group CEO"I am delighted to welcome Peter to the Biocon Group in the role of Group CEO. Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, C...
- Devastated to lose my husband: Kiran Mazumdar-Shaw"I am devastated to lose my husband, my mentor and soul mate. I will always be spiritually guided by John as I pursue my purpose. Rest in P...
- Biocon founder Kiran Mazumdar-Shaw's husband, John Shaw, passes awayBorn in 1949, Shaw served as the Vice Chairman and non-executive director of Biocon and has been on the board since 1999. He was the foreig...
- Biocon Biologics approves primary equity investment by ADQ worth Rs 555 croreAs per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, val...
- Biocon Biologics, Voluntis tie up on digital therapeutics for people with diabetesInsulia provides automated insulin dose recommendations and coaching messages for people with diabetes, while enabling the healthcare team ...
- Biocon elevates M B Chinappa as CFO of biosimilar subsidiaryM B Chinappa, who is going to play an important role in Biocon Biologics’ journey towards becoming a global leader in biologics, has been t...
- Biocon gets EIR from USFDA for Bengaluru biologics unitBiopharma major Biocon reportedly received an Establishment Inspection Report (EIR) from US-FDA for its biologics drug product unit at Beng...
- Licensing deals help Biocon post healthy Q3 nosBiocon's third quarter consolidated net profit rose 24% to 100.75 helped by inflows from licensing deals with global biggies Pfizer and Myl...
- Biocon Q4 profit zooms to Rs 81 croreBiotechnology major Biocon's net profit for the fourth quarter rose sharply after revenues increased and a forex loss of Rs 41.4 crore had ...
- Biocon acquires 49% Cuban partner CIMAB’s stake in JVBiocon has fully acquired the joint venture Biocon Biopharmaceuticals from its Cuban partner CIMAB.
- Biocon LTD signs MoU with Malaysian-based BiotechCorpBiocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investmen...
- Biocon in licensing deals in N America, EuropeUnder the agreement, Biocon will receive an upfront licensing fee, and following approval in the licensed territories, royalties from sales.
- Biocon forms JV with Abu Dhabi-based coThe joint-venture with Neopharma is an important milestone for Biocon's global foray.
Load More
